Advancement in Understanding Rare Pregnancy Complication by Researchers
University of Liverpool researchers, dedicated to bettering the health of women and babies, have led one of the largest studies to understand the premature breaking of waters (PPROM) in pregnant women before 23 weeks’ gestation. Their work provides significant insights to help support women, families, and health care professionals.
Babies develop inside a bag of fluid called the amniotic sac. PPROM (Preterm Prelabour Rupture Of Membranes) is a pregnancy complication where the amniotic sac membranes break too early. Most women who have preterm prelabour rupture of membranes (PPROM) occurring after 24 weeks of pregnancy have a good outlook, with care underpinned by national guidelines.
However, for the one in 1000 women who experience early PPROM between 16- and 23-weeks’ of pregnancy, the current initiatives to improve pregnancy outcomes need to be improved. The outlook for the babies after PPROM under 23 weeks’ gestation is often judged to be so poor that termination is offered, and in many cases advised. However, very little evidence exists about the optimal management of early PPROM from which to formulate guidelines.
In 2010, during her first pregnancy, Ciara Curran experienced the uncertainty and distress that the lack of knowledge about this condition causes when her waters broke at 20 weeks of pregnancy. A week after losing her waters Ciara developed sepsis and went on to give birth to Sinead who was stillborn.
Subsequently, Ciara established Little Heartbeats, a support and advocacy group for women and families. Ciara aims to provide women with accurate, evidence-based information to empower them by understanding PPROM and its risks, enabling them to ask informed questions about their care.
Ciara approached Dr Angharad Care and Dr Laura Goodfellow, Department of Women’s & Children’s Health at the University of Liverpool to discuss ways to better understand the consequences of PPROM before 23 weeks of pregnancy. They accepted the challenge and worked with Little Heartbeats, and the UK Obstetric Surveillance System (UKOSS), University of Oxford, to conduct a study of more than 300 women to better understand outcomes of PRROM before 23 weeks’ of pregnancy.
Dr Laura Goodfellow, one of the lead investigators of the study said: “Sadly, a difficult situation is often made even worse for women with early PPROM because healthcare staff lack guidance about how to manage their care. Conflicting information adds to psychological distress for women and families facing early PPROM. We cannot understate the gravitas of the decision to end a wanted pregnancy for women and their families. In this vulnerable position, they rely heavily on doctors’ advice and require evidence to help support their decision making. We were passionate about conducting this research to ensure women have access to the best information.”
The study shows that neonatal survival, although still quite low, is now better than previously understood. Two thirds of women in the UK now continue their pregnancies, of whom 44% have babies born alive and 26% take home surviving babies. Furthermore, over half of the surviving babies do not appear to have severe morbidity at discharge. The study also shows there is a risk of maternal death secondary to sepsis in women with early PPROM. Importantly, 10% of women who opted for termination of pregnancy after they had first seen a doctor with early PPROM still developed sepsis, compared with 13% of women who initially chose to continue their pregnancy—and is a reminder that infection can be the cause rather than the consequence of early PPROM. Therefore, immediate terminations might not avoid all maternal deaths, and these patients should be recognised as high risk with early involvement of senior members of staff in their care.
Dr Goodfellow continued: “PPROM under 23 weeks’ gestation is too uncommon for one clinician to gain adequate experience from clinical practice alone, or to facilitate interventional research at a small number of centres. But it is common enough that at the UK population level, it affects many women. Our research provides data to allow more unified counselling about the outlook for women and babies after early PPROM and informed decisions about whether to continue a pregnancy.
“Now that we understand the level of risk attributed to this pathology, we need expert consensus, evidence-based research, clinical guidelines, and a reorganisation of services to give the best care for these women and babies. We also need to understand how to best communicate these results, which are quite complex, with women and families. This includes understanding what information women facing PPROM want to know, and giving healthcare professionals the tools to provide that.”
Ciara Curran at Women of the Year awards
Ciara explains how this work can positively impact women with PPROM less than 23 weeks of pregnancy both now and in the future: “I see this research as crucial for advancing understanding of PPROM, supporting the development of national guidelines, patient resources and to secure funding for more research. Raising awareness about PPROM is essential to combatting stigma and improving outcomes for affected pregnancies, to help save lives and understand how we can make it safe for women regardless of their informed choices and to prevent baby loss. I promised my baby daughter, Sinead, she would change things to improve care for women, in her memory and it feels that after 14 years it is starting to become a reality.”
The study was funded and supported by Wellbeing of Women in partnership with Little Heartbeats. Wellbeing of Women funds vital research to improve women’s reproductive and gynaecological health across the life course. Little Heartbeats, the UK Obstetric Surveillance System team at the University of Oxford and doctors and midwives from maternity hospitals across the UK also contributed to this work. Significantly, women such as Ciara, who have experienced baby loss due to PPROM have also contributed with their time and fundraising to raise awareness of the condition.